We use both our own and third-party cookies for statistical purposes and to improve our services. If you continue to browse, we consider that you accept the use of these.

Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrism


“As cells continually transcribe and translate genetic information, the RNA intermediary may be a means of providing profound new insights into the health of any given tissue.”


“the [ImmunoPrism] assay has been able to define gene expression signals and identify immune cell signatures that differentiate patients who remain disease-free after three years from those who [...]

Start typing and press Enter to search